Home LiteratureArticle Details
PMID: 21822286 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization.

Nature medicine ·Vol. 17 ·No. 9 ·2011-08-07 ·Pages 1101-8

Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celià-Terrassa T, Mercatali L, Khan Z, Goodarzi H, Hua Y, Wei Y, Hu G, Garcia BA, Ragoussis J, Amadori D, Harris AL, Kang Y

Abstract

Although the role of miR-200s in regulating E-cadherin expression and epithelial-to-mesenchymal transition is well established, their influence on metastatic colonization remains controversial. Here we have used clinical and experimental models of breast cancer metastasis to discover a pro-metastatic role of miR-200s that goes beyond their regulation of E-cadherin and epithelial phenotype. Overexpression of miR-200s is associated with increased risk of metastasis in breast cancer and promotes metastatic colonization in mouse models, phenotypes that cannot be recapitulated by E-cadherin expression alone. Genomic and proteomic analyses revealed global shifts in gene expression upon miR-200 overexpression toward that of highly metastatic cells. miR-200s promote metastatic colonization partly through direct targeting of Sec23a, which mediates secretion of metastasis-suppressive proteins, including Igfbp4 and Tinagl1, as validated by functional and clinical correlation studies. Overall, these findings suggest a pleiotropic role of miR-200s in promoting metastatic colonization by influencing E-cadherin-dependent epithelial traits and Sec23a-mediated tumor cell secretome.

MeSH Terms
Animals Cadherins/metabolism Cell Line, Tumor Female Gene Expression Profiling Gene Expression Regulation, Neoplastic/physiology Humans Mass Spectrometry Mice Mice, Inbred BALB C MicroRNAs/metabolism Microarray Analysis Neoplasm Metastasis/physiopathology Statistics, Nonparametric Vesicular Transport Proteins/metabolism
Chemicals
Cadherins MIRN200 microRNA, human MicroRNAs Sec23a protein, mouse Vesicular Transport Proteins
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Korpal Manav
Department of Molecular Biology, Princeton University, Princeton, New Jersey, USA.
Ell Brian J
Buffa Francesca M
Ibrahim Toni
Blanco Mario A
Celià-Terrassa Toni
Mercatali Laura
Khan Zia
Goodarzi Hani
Hua Yuling
Wei Yong
Hu Guohong
Garcia Benjamin A
Ragoussis Jiannis
Amadori Dino
Harris Adrian L
Kang Yibin
References (51)
51 references, click to expand
  1. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
    Nature. 2007 Oct 11;449(7163):682-8 PMID: 17898713
  2. Epithelial-mesenchymal transition (EMT) is not sufficient for spontaneous murine breast cancer metastasis.
    Dev Dyn. 2008 Oct;237(10):2755-68 PMID: 18773493
  3. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR-200 family expression.
    Genes Dev. 2009 Sep 15;23(18):2140-51 PMID: 19759262
  4. Mammalian microRNAs predominantly act to decrease target mRNA levels.
    Nature. 2010 Aug 12;466(7308):835-40 PMID: 20703300
  5. c-Myc-regulated microRNAs modulate E2F1 expression.
    Nature. 2005 Jun 9;435(7043):839-43 PMID: 15944709
  6. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis.
    Nat Cell Biol. 2010 Mar;12(3):247-56 PMID: 20173740
  7. Epithelial-mesenchymal transitions in development and disease.
    Cell. 2009 Nov 25;139(5):871-90 PMID: 19945376
  8. Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers.
    J Oncol. 2010;2010:821717 PMID: 20049172
  9. Endogenous human microRNAs that suppress breast cancer metastasis.
    Nature. 2008 Jan 10;451(7175):147-52 PMID: 18185580
  10. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).
    J Biol Chem. 2007 May 11;282(19):14328-36 PMID: 17363372
  11. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer.
    Clin Cancer Res. 2008 Mar 1;14(5):1340-8 PMID: 18316553
  12. MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer.
    Genes Dev. 2009 Sep 15;23(18):2152-65 PMID: 19759263
  13. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system.
    J Clin Oncol. 2007 May 20;25(15):2127-32 PMID: 17513820
  14. A microRNA-based gene dysregulation pathway in Huntington's disease.
    Neurobiol Dis. 2008 Mar;29(3):438-45 PMID: 18082412
  15. microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling.
    Proc Natl Acad Sci U S A. 2010 May 4;107(18):8231-6 PMID: 20406904
  16. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1.
    Mol Cell. 2010 Jun 25;38(6):908-15 PMID: 20620960
  17. MicroRNA expression profiles in serous ovarian carcinoma.
    Clin Cancer Res. 2008 May 1;14(9):2690-5 PMID: 18451233
  18. Genes that mediate breast cancer metastasis to lung.
    Nature. 2005 Jul 28;436(7050):518-24 PMID: 16049480
  19. Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming.
    Cell Stem Cell. 2010 Jul 2;7(1):64-77 PMID: 20621051
  20. Efficient coupling of Sec23-Sec24 to Sec13-Sec31 drives COPII-dependent collagen secretion and is essential for normal craniofacial development.
    J Cell Sci. 2008 Sep 15;121(Pt 18):3025-34 PMID: 18713835
  21. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources.
    Nat Protoc. 2009;4(1):44-57 PMID: 19131956
  22. Expression of E-cadherin in human ductal breast cancer carcinoma in situ, invasive carcinomas, their lymph node metastases, their distant metastases, carcinomas with recurrence and in recurrence.
    Anticancer Res. 2007 Jul-Aug;27(4A):1969-74 PMID: 17649807
  23. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells.
    Breast Cancer Res Treat. 2001 Jan;65(2):101-10 PMID: 11261825
  24. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis.
    Cell Res. 2008 Mar;18(3):350-9 PMID: 18270520
  25. The conserved microRNA miR-8 tunes atrophin levels to prevent neurodegeneration in Drosophila.
    Cell. 2007 Oct 5;131(1):136-45 PMID: 17923093
  26. Oncomirs - microRNAs with a role in cancer.
    Nat Rev Cancer. 2006 Apr;6(4):259-69 PMID: 16557279
  27. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis.
    APMIS. 2007 Jan;115(1):52-65 PMID: 17223851
  28. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer.
    Oncogene. 2008 Apr 3;27(15):2128-36 PMID: 17968323
  29. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition.
    Cancer Res. 2008 Oct 1;68(19):7846-54 PMID: 18829540
  30. Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells.
    Cell. 2009 Aug 7;138(3):592-603 PMID: 19665978
  31. An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients.
    Breast Cancer Res Treat. 2010 Oct;123(3):725-31 PMID: 20020197
  32. Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cells.
    Mol Cell. 2010 Sep 10;39(5):761-72 PMID: 20832727
  33. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.
    EMBO Rep. 2008 Jun;9(6):582-9 PMID: 18483486
  34. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis.
    Dev Cell. 2008 Jun;14(6):818-29 PMID: 18539112
  35. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2.
    Genes Dev. 2008 Apr 1;22(7):894-907 PMID: 18381893
  36. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.
    Lancet. 2005 Feb 19-25;365(9460):671-9 PMID: 15721472
  37. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs.
    Nat Cell Biol. 2009 Dec;11(12):1487-95 PMID: 19935649
  38. Regulation of endoplasmic reticulum stress response by a BBF2H7-mediated Sec23a pathway is essential for chondrogenesis.
    Nat Cell Biol. 2009 Oct;11(10):1197-204 PMID: 19767744
  39. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.
    Cancer Res. 2006 Dec 1;66(23):11271-8 PMID: 17145872
  40. MicroRNAs: target recognition and regulatory functions.
    Cell. 2009 Jan 23;136(2):215-33 PMID: 19167326
  41. Mesenchymal to epithelial transition in development and disease.
    Cells Tissues Organs. 2007;185(1-3):7-19 PMID: 17587803
  42. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
    Nat Cell Biol. 2008 Feb;10(2):202-10 PMID: 18193036
  43. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis.
    Cell. 2004 Jun 25;117(7):927-39 PMID: 15210113
  44. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1.
    Nat Cell Biol. 2008 May;10(5):593-601 PMID: 18376396
  45. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2.
    J Biol Chem. 2008 May 30;283(22):14910-4 PMID: 18411277
  46. A pleiotropically acting microRNA, miR-31, inhibits breast cancer metastasis.
    Cell. 2009 Jun 12;137(6):1032-46 PMID: 19524507
  47. EMT and MET in carcinoma--clinical observations, regulatory pathways and new models.
    Clin Exp Metastasis. 2008;25(6):591-2 PMID: 18566898
  48. A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation.
    J Cell Biol. 2008 Aug 11;182(3):509-17 PMID: 18695042
  49. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor.
    Cancer Res. 1992 Mar 15;52(6):1399-405 PMID: 1540948
  50. miR-200 enhances mouse breast cancer cell colonization to form distant metastases.
    PLoS One. 2009 Sep 29;4(9):e7181 PMID: 19787069
  51. Secretory COPII coat component Sec23a is essential for craniofacial chondrocyte maturation.
    Nat Genet. 2006 Oct;38(10):1198-203 PMID: 16980978
Article Info
Journal
Nature medicine
Abbr.
Nat Med
ISSN
1546-170X
Published
2011-08-07
Epub
2011-00-07
Pages
1101-8
Language
English
Region
United States
NLM ID
9502015
PMCID
PMC3169707
Subset
IM
Grants
NCI NIH HHS · P30 CA072720 · United States
NCI NIH HHS · R01 CA141062-03 · United States
NCI NIH HHS · R01 CA141062 · United States
Wellcome Trust · 090532 · United Kingdom
NCI NIH HHS · R01 CA141062-01A1 · United States
NCI NIH HHS · R01 CA134519 · United States
NCI NIH HHS · R01 CA141062-02 · United States
Cancer Research UK · United Kingdom
NCI NIH HHS · R01 CA134519-04 · United States
NCI NIH HHS · 1R01-CA141062 · United States
Databases
GEO
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com